Guardant Health Shield FDA Approval

Quote












anonymous said:
It misses half of stage one cancer and most adenomas. Doctors/systems don't get quality credit. And it will cost $900 a year.

To say "it's over" on this alone is laughable.
Click to expand...
Listen moron, keep thinking this and see what happens. Coupled with upcoming earnings this is a shit week for our company.

Meanwhile where are our FAQs for when our docs ask about this?? Whyyyy is everyone here so fucking unprepared and constantly selling from behind?
 






anonymous said:
It misses half of stage one cancer and most adenomas. Doctors/systems don't get quality credit. And it will cost $900 a year.

To say "it's over" on this alone is laughable.
Click to expand...
Oh another kool aid drinker who just listens to the idiots in leadership with their half baked thoughts. Shield has previously been available with that OOP cost but FDA approval opens the door to Medicaid, Medicare and payer coverage. Fact is blood is a game changer for a lot of customers and no one has prepared us to sell against it.
 






anonymous said:
Oh another kool aid drinker who just listens to the idiots in leadership with their half baked thoughts. Shield has previously been available with that OOP cost but FDA approval opens the door to Medicaid, Medicare and payer coverage. Fact is blood is a game changer for a lot of customers and no one has prepared us to sell against it.
Click to expand...
Agreed. It’s a Simple Blood Draw. Convenient.
 






It is strange, but people do not like to shit in boxes. On the other hand the blood test will increase the chance of dying or dealing with more severe disease . Which one will be the most powerful motivator - not shitting in a box or increased risk of dying?
 






ES has it's own CRC blood based test in the works. Problem is they are dragging their feet once again, always behind. Its to be submitted for FDA approval in H2 2025. The company is faultering for multiple reasons. This is just another one to add to the list.
 






Our company is always behind. We can’t even launch an updated Cologuard since apparently we are proposing a 25% price increase for Cologuard Plus regardless that it’s less expensive to manufacture, and the advisory panel for Medicare is the first to balk. Greedy assholes!! We aren’t even prepared to sell current Cologuard against Shield!
 






anonymous said:
ES has its own CRC blood based test in the works. Problem is they are dragging their feet once again, always behind. It’s to be submitted for FDA approval in H2 2025. The company is faultering for multiple reasons. This is just another one to add to the list.
Click to expand...
Markets are forward looking. This may get ugly for the stock price later this year unless ES comes up with something else to fuel growth in 2026 and beyond. Kevin’s job is to tell everyone things have never been better at ES. Like the captain of the Titanic telling the band to keep playing.
 






anonymous said:
Markets are forward looking. This may get ugly for the stock price later this year unless ES comes up with something else to fuel growth in 2026 and beyond. Kevin’s job is to tell everyone things have never been better at ES. Like the captain of the Titanic telling the band to keep playing.
Click to expand...
Except Kevin doesn't say hardly anything these days. He's been mostly MIA. Perhaps if he reiterates ES attracts top talent it'll come true one day.
 










































Guardent just struck a deal to have Quest diagnostics process their blood test. With Quests network of patient service centers to draw specimens and the Quest account representatives selling the test it's game over for Cologuard!
 






Top Bottom
Back
Quote